Old Web
English
Sign In
Acemap
>
Paper
>
MP66-02 INHIBITION OF LIM-SH3 DOMAIN PROTEIN1 AUGMENTS THE ANTI-CANCER EFFECT OF ENZALUTAMIDE IN PROSTATE CANCER.
MP66-02 INHIBITION OF LIM-SH3 DOMAIN PROTEIN1 AUGMENTS THE ANTI-CANCER EFFECT OF ENZALUTAMIDE IN PROSTATE CANCER.
2015
Takashi Dejima
Ario Takeuchi
Jeffrey Leong
Tabitha Tombe
Kevin J. Tam
Seiji Naito
Martin Gleave
Christopher J. Ong
Keywords:
Urology
Prostate cancer
Cancer
SH3 domain
Enzalutamide
Medicine
Cancer research
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]